DKK1-Targeting Cholesterol-Modified siRNA Implication in Hair Growth Regulation

    Dimitri Papukashvili, Cong Liu, Nino Rcheulishvili, Fengfei Xie, Xinyun Wang, Shunping Feng, Xiaonan Sun, Chi Zhang, Yingyu Li, Yaohua He, Peng George Wang
    Image of study
    TLDR Blocking DKK1 with siRNA can improve hair growth.
    The study "DKK1-targeting cholesterol-modified siRNA implication in hair growth regulation" investigates the role of DKK1, an inhibitor of the Wnt/β-catenin signaling pathway, in hair growth. The researchers found that patients with androgenetic alopecia (AGA) had significantly higher concentrations of DKK1 in their scalp tissue. The study used small interfering RNA (siRNA) technology to target DKK1, with the siRNA sequence validated in vitro and in vivo through subcutaneous injections on mice. The results showed that DKK1-targeting siRNA significantly enhanced hair regeneration compared to the control group, suggesting that inhibiting DKK1 could be a critical factor in promoting hair growth and developing an effective treatment for AGA.
    Discuss this study in the Community →

    Research cited in this study

    13 / 13 results

    Related Community Posts Join

    6 / 16 results

      community Better Than Minoxidil? Topical Sodium Valproate

      in Research/Science  51 upvotes 1 month ago
      Topical sodium valproate may promote hair growth by inhibiting GSK3β, allowing beta-catenin to proliferate, but it has potential side effects and requires more research. The conversation also mentions skepticism about a product called Vdphlo1, which includes sodium valproate and other ingredients.

      community Has anyone used Magnesium L-Threonate ?

       74 upvotes 6 years ago
      Magnesium L-Threonate may help treat balding by reducing DKK-1 expression without affecting DHT. Users discuss its potential effectiveness and application methods, with some considering trying it topically.

      community Breezula phase 3 results said to be released next month

      in Product  28 upvotes 3 months ago
      Breezula's phase 3 results are expected soon, with discussions on the effectiveness of androgen receptor antagonists like spironolactone and the potential of GT20029. Users express skepticism about new treatments and discuss the complexities of male pattern baldness, often relying on finasteride despite its side effects.

    Similar Research

    5 / 553 results